Tenax Therapeutics (TENX) Notes Payables (2011 - 2024)
Tenax Therapeutics (TENX) posted quarterly Notes Payables of $278802.0 for Q2 2024, down 19.36% year-over-year from $345749.0 in Q3 2023, and down 32.52% on a QoQ basis from $413174.0 in Q1 2024.
Tenax Therapeutics (TENX) Notes Payables (2011 - 2024) Analysis & Trends
Tenax Therapeutics has reported Notes Payables for 8 years, with the latest figure at $278802.0 in Q2 2024.
- Notes Payables for Q2 2024 came in at $278802.0, down 19.36% year-over-year; the trailing twelve-month figure through Jun 2024 was $278802.0 (down 19.36% YoY), and the FY2023 annual result was $501000.0, down 19.75% from the prior year.
- Notes Payables retreated to $278802.0 in Q2 2024, from $413174.0 in the prior quarter.
- Over five years, Notes Payables peaked at $624302.0 in Q4 2022 and troughed at $30900.0 in Q3 2020.
- A 5-year average of $280354.6 and a median of $228762.0 in 2022 frame the typical range for Notes Payables.
- The largest YoY upside for Notes Payables was 276.33% in 2023 against a maximum downside of 19.75% in 2023.
- A 5-year view of Notes Payables shows it stood at $120491.0 in 2020, then soared by 77.26% to $213577.0 in 2021, then surged by 192.31% to $624302.0 in 2022, then decreased by 19.75% to $501000.0 in 2023, then sank by 44.35% to $278802.0 in 2024.
- Per Business Quant data, the three most recent Notes Payables figures were $278802.0 in Q2 2024, $413174.0 in Q1 2024, and $501000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 278,802.00 |
| Mar 31, 2024 | 413,174.00 |
| Dec 31, 2023 | 501,000.00 |
| Sep 30, 2023 | 174,466.00 |
| Jun 30, 2023 | 345,749.00 |
| Mar 31, 2023 | 513,906.00 |
| Dec 31, 2022 | 624,302.00 |
| Jun 30, 2022 | 91,875.00 |
| Mar 31, 2022 | 228,762.00 |
| Mar 31, 2021 | 213,577.00 |
| Dec 31, 2020 | 120,491.00 |
| Sep 30, 2020 | 30,900.00 |
| Jun 30, 2020 | 107,606.00 |
| Apr 30, 2013 | 57,539.00 |
| Jan 31, 2013 | 98,657.00 |
| Oct 31, 2012 | 7,195.00 |
| Jul 31, 2012 | 21,223.00 |
| Apr 30, 2012 | 62,958.00 |
| Jan 31, 2012 | 104,178.00 |
| Oct 31, 2011 | 7,195.00 |